Jan 30, 2024 / 01:30PM GMT
Operator
Hello, everybody, and welcome to the Iterum Therapeutics P3 REASSURE clinical trial results. After the speakers' remarks, there will be a question and answer session. (Operator Instructions)
It's now my pleasure to turn the conference over to Louise Barrett, Senior Vice President, Legal Affairs.
Louise Barrett Iterum Therapeutics PLC-SVP - Legal Affairs
Thank you, Drew. Good morning and welcome to the Iterum Therapeutics Phase 3 REASSURE clinical trial results conference call. A press release with our top end results was issued earlier this morning and can be found on our website.
The press release also the link to the webcast. And if you're not using the webcast, the slides will be referencing are available on our website, www.iterumtx.com under the heading Investors and Events and Presentations. And also filed as an exhibit to our current report on Form 8-K filed this morning with the SEC.
We are joined this morning by our Chief Executive Officer,
Iterum Therapeutics PLC Phase 3 Topline Data Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
